Navigation Links
Major rise in Caesarean sections linked to impaired womb function with age
Date:7/2/2008

Delaying childbirth has substantially contributed to recent rises in caesarean section rates, according to a paper published this week by scientists at Cambridge University.

The findings come from an analysis of a large body of Scottish data performed by a team under Professor Gordon Smith, at the University's Department of Obstetrics and Gynaecology.

The team examined more than 500,000 entries collected by the Scottish Morbidity Record between 1980 and 2005 to determine the association between maternal age and the outcome of labour. Alongside a major increase in the number of caesareans, they found striking changes in the age of mothers over the study period.

The proportion of women aged 35-39 entering their first pregnancy increased seven-fold, whilst there was a ten-fold increase for women aged 40 or older. At the same time, the caesarean rate more than doubled. The team estimate that 38% of these additional procedures would have been avoided if the maternal age distribution had remained static.

This picture is mirrored elsewhere in the developed world, which has seen a dramatic increase in caesarean sections over the past thirty years. Previous epidemiological studies had also reported a correlation with maternal age, but the reason for the increased rate remained unclear.

Hypothesising that there was a biological cause, the team went on to study samples of the myometrium, muscle from the middle of the uterine wall, taken from 62 women undergoing elective caesarean procedures in Cambridge.

They found that advancing age was associated with impaired uterine function, in particular a reduced degree of spontaneous contraction and change in the type of contraction. The reduction is thought to result in poor progression of labour and thus the increased rate of caesarean section.

The findings, which are published this week in Public Library of Science Medicine, will have implications for p
'/>"/>

Contact: Tom Russell
tom.russell@admin.cam.ac.uk
44-012-233-32300
University of Cambridge
Source:Eurekalert

Page: 1 2

Related medicine news :

1. J.D. Power and Associates Reports: A Vast Majority of Southern California Indian Gaming Casino Customers Express Desire for a Smoke-Free Environment
2. BRAVA Breast Enhancement System Hits Major Milestone
3. American Academy of Dermatology, Major League Baseball and Major League Baseball Players Association Play Sun Smart(TM) to Strike Out Skin Cancer
4. Building the New Majority Launches Grassroots GOP Effort in New Jersey
5. Major Associations Band Together to Urge Congressional Action on Tobacco Legislation
6. Report: NIH and Global Health Research are a Major Boon to All State Economies
7. Alijor.com Now Offers Price Summaries for Healthcare Services in Major U.S. Cities
8. Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
9. Consumers Can Purchase Majority of Tomato Varieties
10. Majority of U.S. House Supports Repeal of Medicare Therapy Caps
11. SXC Health Solutions to provide technology services and support to major PBM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Global Health Innovative Technology Fund (GHIT Fund), a ... know-how and investment to the global fight against ... US$15.3 million to speed the development of promising ... dengue and Chagas disease. The announcement marks the ... November 2013totaling $33.5 millionaimed at diseases that sicken ...
(Date:9/15/2014)... September 15, 2014 Ondine Biomedical ... Loebel, its President and Chief Technology Officer, will ... Photodynamic Therapy (PDT) and Photodiagnosis in Clinical Practice. ... Brixen/Bressanone (Italy) from October 14-18, 2014 alongside the ... on October 13-14th, is an annual conference at ...
(Date:9/15/2014)... VA (PRWEB) September 15, 2014 ... and management consulting services to the federal government, ... in Alexandria, Virginia and Atlanta, Georgia to better ... catalyst for this expansion is credited to the ... in the core areas of management consulting, agile ...
(Date:9/15/2014)... out of every 40 individuals in the United States is ... (SMA), a neurodegenerative disease that causes muscles to weaken over ... a recent breakthrough with the development of a new compound ... disease. In April, a patent was filed for the compound ... using to fight SMA is to ,repress the repressor," said ...
(Date:9/15/2014)... In order to provide predictability and safety, the ... quantify, define and model medical practice. Defined as Bioinformatics ... medical care. , The Journal of BioAcoustic Biology ( ... non-profit Institute of BioAcoustic Biology, located in Albany, Ohio, ... much more than a measurement tool; math, as frequency, ...
Breaking Medicine News(10 mins):Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 2Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 3Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 4Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 5Health News:Ondine Presenting at the 2014 International Symposium on Photodynamic Therapy and Photodiagnosis 2Health News:Octo Consulting Group Announces it is Opening Two New Offices in Alexandria, Virginia and Atlanta, Georgia to Better Serve Existing and Future Federal Government Clients 2Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3
... survival rate of non-small-cell lung cancer patients after ... Cisplatin is an anti-neoplastic medication that interferes with ... growth and spread in the body. ... three or four cycles of cisplatin-based chemotherapy or ...
... the world's first epilepsy drug, an Australian neurologist says.// ... a mild sedative, taken either as a herbal infusion ... form. ,But the Italian author Fabio Colonna first ... botanical work Phytobasanos. ,Colonna said he had controlled ...
... around 700,000 people researchers say dads who have children ... // for developing schizophrenia later in life. ... to the hospital in Sweden between 1989 and 2001 ... Researchers say they found a strong association between the ...
... recent study shows that people who use stomach-acid suppressive ... may be at an increased risk of developing pneumonia ... the stomach can increase vulnerability to infections, as stomach ... Researchers studied pneumonia rates of more than 364,000 patients ...
... study researchers say they have found that the drug ... cancer // decreased patients' cancer incidence after 12 months ... some impact, but the 20-milligram dose had the greatest ... prostatic intraepithelial neoplasia, characterized by abnormal cells in the ...
... New research shows that sleep disorders may be linked ... ADD ), // neuromuscular conditions, and psychiatric problems. ... patients with sleep apnea also had ADD. Results also ... insomnia. Further testing showed some of these patients also ...
Cached Medicine News:Health News:Valerian was first epilepsy drug 2
(Date:9/15/2014)... SALT LAKE CITY , Sept. 15, 2014 ... innovative minimally invasive surgical (MIS) visualization products, is ... 13485:2003 certification for its quality management system (QMS) ... is another important step in Olive Medical complying ... of medical devices.  It is the goal of ...
(Date:9/15/2014)... CHICAGO , Sept. 15, 2014  The Female ... Tayler will join the Company,s management team as ... 2014.  The Company also announced that Michael Pope ... U.K. and Malaysian Operations, effective September 15, 2014.  Following ... the Company as a Consultant. Prior to ...
(Date:9/15/2014)... , Sept. 15, 2014   Royal Philips ... its growing range of advanced women,s healthcare imaging solutions ... Society for Ultrasound in Obstetrics and Gynecology (ISUOG) World ... Spain . "We,re continually investing ... efficiency and outcomes," said Vitor Rocha , CEO ...
Breaking Medicine Technology:Olive Medical Achieves ISO 13485:2003 Certification 2The Female Health Company Appoints Martin Tayler Executive Vice President of Global Operations 2The Female Health Company Appoints Martin Tayler Executive Vice President of Global Operations 3Philips Showcases Ultrasound Innovations that Address Clinical Challenges in the OB/GYN Segment at ISUOG World Congress 2Philips Showcases Ultrasound Innovations that Address Clinical Challenges in the OB/GYN Segment at ISUOG World Congress 3
... , June 21 ViroPharma Incorporated (Nasdaq: ... Cinryze™ (C1 Esterase Inhibitor [Human]) manufacturing expansion activities.   , ... ViroPharma ...  The first project, the parallel chromatography process, was implemented earlier ...
... , MISGAV, Israel , ... of laparoscopic soft tissue prosthetic placement,technologies, today announced that it ... an innovative laparoscopic,surgical instrument that enables accurate and rapid delivery ... including laparoscopic,ventral hernia repair (LVHR). , ...
Cached Medicine Technology:ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 2ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 3ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 4ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 5ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 6PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects 2PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects 3
...
...
... exercise BP monitor is designed to automatically ... diastolic BP along with heart rate. It's ... use in treadmill, ergometer and pharmacological stress ... use in research environments., ,Tango excels ...
...
Medicine Products: